These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
166 related items for PubMed ID: 3421575
1. Right-sided Staphylococcus aureus endocarditis in intravenous drug abusers: two-week combination therapy. Chambers HF, Miller RT, Newman MD. Ann Intern Med; 1988 Oct 15; 109(8):619-24. PubMed ID: 3421575 [Abstract] [Full Text] [Related]
2. Effectiveness of cloxacillin with and without gentamicin in short-term therapy for right-sided Staphylococcus aureus endocarditis. A randomized, controlled trial. Ribera E, Gómez-Jimenez J, Cortes E, del Valle O, Planes A, Gonzalez-Alujas T, Almirante B, Ocaña I, Pahissa A. Ann Intern Med; 1996 Dec 15; 125(12):969-74. PubMed ID: 8967707 [Abstract] [Full Text] [Related]
3. [Right endocarditis caused by Staphylococcus aureus in parenteral drug addicts: evaluation of a combined therapeutic scheme for 2 weeks versus conventional treatment]. Espinosa FJ, Valdés M, Martín-Luengo F, Arribas JP, Albaladejo J, Pérez-Gracia A, García-Henarejos JA, Martínez-Madrid O, García-Alberola A. Enferm Infecc Microbiol Clin; 1993 May 15; 11(5):235-40. PubMed ID: 8324018 [Abstract] [Full Text] [Related]
4. Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users. Small PM, Chambers HF. Antimicrob Agents Chemother; 1990 Jun 15; 34(6):1227-31. PubMed ID: 2393284 [Abstract] [Full Text] [Related]
5. Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: A prospective study. Korzeniowski O, Sande MA. Ann Intern Med; 1982 Oct 15; 97(4):496-503. PubMed ID: 6751182 [Abstract] [Full Text] [Related]
6. Teicoplanin versus nafcillin and vancomycin in the treatment of experimental endocarditis caused by methicillin-susceptible or -resistant Staphylococcus aureus. Chambers HF, Sande MA. Antimicrob Agents Chemother; 1984 Jul 15; 26(1):61-4. PubMed ID: 6236747 [Abstract] [Full Text] [Related]
7. Right-sided staphylococcal endocarditis. Monane M, Gabelman GS, Cohen E, Karpel JP. Ann Intern Med; 1989 May 01; 110(9):749-50. PubMed ID: 2930112 [No Abstract] [Full Text] [Related]
8. Bacteriological efficacy of nafcillin and vancomycin alone or combined with rifampicin or amikacin in experimental meningitis due to methicillin-susceptible or -resistant Staphylococcus aureus. Sato K, Lin TY, Weintrub L, Olsen K, McCracken GH. Jpn J Antibiot; 1985 Aug 01; 38(8):2155-62. PubMed ID: 3852897 [Abstract] [Full Text] [Related]
9. Nafcillin-gentamicin synergism in experimental staphylococcal endocarditis. Sande MA, Courtney KB. J Lab Clin Med; 1976 Jul 01; 88(1):118-24. PubMed ID: 1047088 [Abstract] [Full Text] [Related]
10. Retrospective evaluation of therapies for Staphylococcus aureus endocarditis. Gentry CA, Rodvold KA, Novak RM, Hershow RC, Naderer OJ. Pharmacotherapy; 1997 Jul 01; 17(5):990-7. PubMed ID: 9324187 [Abstract] [Full Text] [Related]
11. Ciprofloxacin therapy of experimental endocarditis caused by methicillin-susceptible or methicillin-resistant Staphylococcus aureus. Fernandez-Guerrero M, Rouse M, Henry N, Wilson W. Antimicrob Agents Chemother; 1988 May 01; 32(5):747-51. PubMed ID: 3164989 [Abstract] [Full Text] [Related]
12. Successful therapy of experimental endocarditis caused by vancomycin-resistant Staphylococcus aureus with a combination of vancomycin and beta-lactam antibiotics. Fox PM, Lampen RJ, Stumpf KS, Archer GL, Climo MW. Antimicrob Agents Chemother; 2006 Sep 01; 50(9):2951-6. PubMed ID: 16940087 [Abstract] [Full Text] [Related]
13. Efficacy of vancomycin plus rifampin in experimental aortic-valve endocarditis due to methicillin-resistant Staphylococcus aureus: in vitro-in vivo correlations. Bayer AS, Lam K. J Infect Dis; 1985 Jan 01; 151(1):157-65. PubMed ID: 3965588 [Abstract] [Full Text] [Related]
14. Resurgence of Pseudomonas endocarditis in Detroit, 2006-2008. Reyes MP, Ali A, Mendes RE, Biedenbach DJ. Medicine (Baltimore); 2009 Sep 01; 88(5):294-301. PubMed ID: 19745688 [Abstract] [Full Text] [Related]
16. Efficacy of ampicillin plus a beta-lactamase inhibitor (CP-45,899) in experimental endocarditis due to Staphylococcus aureus. Washburn RG, Durack DT. J Infect Dis; 1981 Sep 01; 144(3):237-43. PubMed ID: 6268715 [Abstract] [Full Text] [Related]
17. Comparison of methicillin, nafcillin, and oxacillin in therapy of Staphylococcus aureus endocarditis in rabbits. Egert J, Carrizosa J, Kaye D, Kobasa WD. J Lab Clin Med; 1977 Jun 01; 89(6):1262-8. PubMed ID: 864305 [Abstract] [Full Text] [Related]
18. Vancomycin or vancomycin plus netilmicin for methicillin- and gentamicin-resistant Staphylococcus aureus aortic valve experimental endocarditis. Perdikaris G, Giamarellou H, Pefanis A, Donta I, Karayiannakos P. Antimicrob Agents Chemother; 1995 Oct 01; 39(10):2289-94. PubMed ID: 8619584 [Abstract] [Full Text] [Related]
19. Evidence of less severe aortic valve destruction after treatment of experimental staphylococcal endocarditis with vancomycin and dexamethasone. Siaperas P, Pefanis A, Iliopoulos D, Katsarolis I, Kyroudi-Voulgari A, Donta I, Karayiannakos P, Giamarellou H. Antimicrob Agents Chemother; 2001 Dec 01; 45(12):3531-7. PubMed ID: 11709335 [Abstract] [Full Text] [Related]
20. Staphylococcal endocarditis. Laboratory and clinical basis for antibiotic therapy. Karchmer AW. Am J Med; 1985 Jun 28; 78(6B):116-27. PubMed ID: 3893113 [Abstract] [Full Text] [Related] Page: [Next] [New Search]